SCHEMBL4633167

SCHEMBL4633167

C/C=C\c1cccc(-c2ccccc2)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HNF4A P41235 1/20 0.46
HDAC4 P56524 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 1/20 0.46
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
BCL2L1 Q07817 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BACE1 P56817 3/20 0.39
PDCD1 Q15116 2/20 0.38
CD274 Q9NZQ7 2/20 0.38
GRIN2D O15399 2/20 0.38
GRIN3B O60391 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
GRIN3A Q8TCU5 2/20 0.38
PDE4B Q07343 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633168 1.00 HNF4A (0.46) HNF4AHDAC4HDAC2HDAC8HDAC6
SCHEMBL10584659 0.86 IAPP (0.41) ALDH1A1IAPPESR2ALOX5
SCHEMBL10584658 0.86 IAPP (0.41) ALDH1A1IAPPESR2ALOX5
SCHEMBL6446688 0.82 GRIN2D (0.43) ALDH1A1HPGDBCL2L1HSD17B10BACE1
SCHEMBL1588210 0.82 GRIN2D (0.43) ALDH1A1HPGDBCL2L1HSD17B10BACE1
SCHEMBL9496694 0.82 GRIN2D (0.43) ALDH1A1HPGDBCL2L1HSD17B10BACE1
SCHEMBL8894545 0.80 IAPP (0.45) ALDH1A1HPGDHSD17B10IAPPESR2
SCHEMBL2047855 0.80 IAPP (0.45) ALDH1A1HPGDHSD17B10IAPPESR2
SCHEMBL2047852 0.80 IAPP (0.45) ALDH1A1HPGDHSD17B10IAPPESR2
SCHEMBL6548196 0.79 PDCD1 (0.47) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654266-B1 NOVEL METATHESIS CATALYSTS BOEHRINGER INGELHEIM INT (DE) 2008-06-04 EP disclosed
US-7241898-B2 Metathesis catalysts BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-07-10 US disclosed
EP-1654266-A1 NOVEL METATHESIS CATALYSTS Boehringer Ingelheim International GmbH (DE) 2006-05-10 EP disclosed
US-20050049417-A1 Metathesis catalysts BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-03-03 US disclosed
WO-2005016944-A1 NOVEL METATHESIS CATALYSTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050049417-A1 Metathesis catalysts CYP1B1, MSMO1, CYP1A1 HNF4A 2268/4885HDAC4 4106/4885HDAC2 3378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.